Last update:

Alzheimer's disease & dementia news

Medical research

Dietary compound increases longevity and protects against Alzheimer's disease in experimental models

Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra's group at the University of Kent (U.K.), have shown that the carotenoid phytoene ...

Alzheimer's disease & dementia

Questions over safety and effectiveness of new Alzheimer's drug

The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by The BMJ.

Genetics

Master copper regulator discovery may offer Alzheimer's clues

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...

Alzheimer's disease & dementia

Boosting brain protein levels may slow decline from Alzheimer's

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.

Alzheimer's disease & dementia

Panel of 48 CSF proteins complements existing Alzheimer biomarkers

A panel of 48 proteins in the cerebrospinal fluid (CSF 48 panel) complements existing CSF biomarkers for Alzheimer disease (AD), according to a study published in the Sept. 6 issue of Science Translational Medicine.

Medications

Unlocking how the new Alzheimer's drug lecanemab works

Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be a main driver of the disease. ...

Alzheimer's disease & dementia

New blood test gives high accuracy screen for Alzheimer's disease

A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest ...